Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Women With Breast Cancer 1Colorectal Neoplasms 1Childhood Cancer Survivors 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Perindopril × Clear all
NCT04588935 2023-02-08

Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

State Institution "Republican Scientific and Practical Center" Cardiology, Belarus

Phase 2 Completed
100 enrolled
Breast

Women With Breast Cancer

NCT02651415 2019-09-12

PARICCA

British Columbia Cancer Agency

Phase 2 Completed
12 enrolled 13 charts
Gastrointestinal

Colorectal Neoplasms

NCT01948232 2015-10-06

Pilot Study of Perindopril in Childhood Cancer Survivors

The Hospital for Sick Children

Phase 2 Withdrawn

Childhood Cancer Survivors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡